International Diabetes Federation Satellite Symposium on Diab etes and Macrovascular ComplicationsORIMO, Hajime; NAWATA, Hajime; HARANO, Yutaka et al.Diabetes (New York, NY). 1996, Vol 45, issn 0012-1797, 140 p., SUP3Conference Proceedings

Mechanism and clinical implication of insulin resistance syndromeSUZUKI, M; IKEBUCHI, M; SHINOZAKI, K et al.Diabetes (New York, NY). 1996, Vol 45, pp S52-S54, issn 0012-1797, SUP3Conference Paper

Cytokines, modified lipoproteins, and arteriosclerosis in diabetesLOPES-VIRELLA, M. F; VIRELLA, G.Diabetes (New York, NY). 1996, Vol 45, pp S40-S44, issn 0012-1797, SUP3Conference Paper

Hyperinsulinemia and atherosclerosisSTOUT, R. W.Diabetes (New York, NY). 1996, Vol 45, pp S45-S46, issn 0012-1797, SUP3Conference Paper

Mechanism on disorders of coagulation and fibrinolysis in diabetesMATSUDA, T; MORISHITA, E; JOKAJI, H et al.Diabetes (New York, NY). 1996, Vol 45, pp S109-S110, issn 0012-1797, SUP3Conference Paper

Biochemical and molecular mechanisms in the development of diabetic vascular complicationsKING, G. L; KUNISAKI, M; NISHIO, Y et al.Diabetes (New York, NY). 1996, Vol 45, pp S105-S108, issn 0012-1797, SUP3Conference Paper

Criteria for metabolic control and intervention in diabetesTASKINEN, M. R.Diabetes (New York, NY). 1996, Vol 45, pp S120-S122, issn 0012-1797, SUP3Conference Paper

Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDDMOKUBO, M; MURASE, T.Diabetes (New York, NY). 1996, Vol 45, pp S123-S125, issn 0012-1797, SUP3Conference Paper

Prostacyclin-stimulating factor, novel protein, and diabetic angiopathyUMEDA, F; ONO, Y; MASAKADO, M et al.Diabetes (New York, NY). 1996, Vol 45, pp S111-S113, issn 0012-1797, SUP3Conference Paper

Human arterial smooth muscle cell proliferation in diabetesOIKAWA, S; HAYASAKA, K; HASHIZUME, E et al.Diabetes (New York, NY). 1996, Vol 45, pp S114-S116, issn 0012-1797, SUP3Conference Paper

Infrainguinal reconstruction in diabetesDEPALMA, R. G; TALIEH, Y. J.Diabetes (New York, NY). 1996, Vol 45, pp S126-S128, issn 0012-1797, SUP3Conference Paper

Involvement of glycation and oxidative stress in diabetic macroangiopathyTANIGUCHI, N; KANETO, H; ASAHI, M et al.Diabetes (New York, NY). 1996, Vol 45, pp S81-S83, issn 0012-1797, SUP3Conference Paper

Transgenic mouse and gene therapyHARADA, K; SHIMANO, H; ISHIBASHI, S et al.Diabetes (New York, NY). 1996, Vol 45, pp S129-S132, issn 0012-1797, SUP3Conference Paper

Asymptomatic cerebral small infarcts (Lacunae), Their risk factors and intellectual disturbancesFUSHIMI, H; INOUE, T; YAMADA, Y et al.Diabetes (New York, NY). 1996, Vol 45, pp S98-S100, issn 0012-1797, SUP3Conference Paper

Diabetes and cardiovascular disease in a prospective population survey in Japan : The Hisayama studyFUJISHIMA, M; KIYOHARA, Y; KATO, I et al.Diabetes (New York, NY). 1996, Vol 45, pp S14-S16, issn 0012-1797, SUP3Conference Paper

Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolismSOWERS, J. R.Diabetes (New York, NY). 1996, Vol 45, pp S47-S51, issn 0012-1797, SUP3Conference Paper

Diabetic dyslipidemia : Basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levelsGINSBERG, H. N.Diabetes (New York, NY). 1996, Vol 45, pp S27-S30, issn 0012-1797, SUP3Conference Paper

Intensive insulin therapy in type II Diabetes : Rationale and collaborative clinical trial resultsCOLWELL, J. A.Diabetes (New York, NY). 1996, Vol 45, pp S87-S90, issn 0012-1797, SUP3Conference Paper

RAGE : A novel cellular receptor for advanced glycation end productsSCHMIDT, A. M; HORI, O; CAO, R et al.Diabetes (New York, NY). 1996, Vol 45, pp S77-S80, issn 0012-1797, SUP3Conference Paper

Glycation, oxidative stress, and scavenger activity : Glucose metabolism and radical scavenger dysfunction in endothelial cellsKASHIWAGI, A; ASAHINA, T; NISHIO, Y et al.Diabetes (New York, NY). 1996, Vol 45, pp S84-S86, issn 0012-1797, SUP3Conference Paper

Quantitative and qualitative derangement of apolipoprotein B-Containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjectsHARANO, Y; KAGEYAMA, A; NAKAO, Y et al.Diabetes (New York, NY). 1996, Vol 45, pp S31-S34, issn 0012-1797, SUP3Conference Paper

Vitamin E normalizes diacyglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissuesKUNISAKI, M; FUMIO, U; NAWATA, H et al.Diabetes (New York, NY). 1996, Vol 45, pp S117-S119, issn 0012-1797, SUP3Conference Paper

Insulin suppresses endothelial secretion of C-type natriuretic peptide, a novel endothelium-derived relaxing peptideIGAKI, T; ITOH, H; SUGA, S.-I et al.Diabetes (New York, NY). 1996, Vol 45, pp S62-S64, issn 0012-1797, SUP3Conference Paper

Recent progress in advanced glycation and diabetic vascular disease : Role of advanced glycation end product receptorsVLASSARA, H; BUCALA, R.Diabetes (New York, NY). 1996, Vol 45, pp S65-S66, issn 0012-1797, SUP3Conference Paper

Risk factor analyses for macrovascular complication in nonobese NIDDM patients : Multiclinical Study for Diabetic Macroangiopathy (MSDM)ITO, H; HARANO, Y; UMEDA, F et al.Diabetes (New York, NY). 1996, Vol 45, pp S19-S23, issn 0012-1797, SUP3Conference Paper